DMRC:NASDAQDigimarc Corporation Analysis
Data as of 2026-03-29 - not real-time
$4.47
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Digimarc (DMRC) is trading at $4.47, well below its 20‑day SMA of 5.27 and 50‑day SMA of 5.39, indicating a bearish price position. The MACD histogram is negative (-0.13) with a bearish signal line, and the RSI sits at 38.9, suggesting limited upside momentum. Volume has been trending down, and the stock is approaching its recent support level around $4.07, raising short‑term downside risk. On the fundamentals side, revenue grew modestly 2.9% YoY to $33.9 M, gross margins remain high (~76%) but operating and net margins are deeply negative, and the company posted a negative GAAP EPS of -1.49. However, the latest earnings call highlighted positive non‑GAAP net income, a turnaround to positive free cash flow of $1.55 M, and strategic partnership announcements that could expand the subscription base. The DCF model values the firm at roughly $1.40, implying the current market price is considerably overvalued. With a beta of 1.93 and 30‑day volatility near 97%, the stock is highly sensitive to market swings. The sector (technology‑software) carries inherent high risk, and the lack of a dividend eliminates any income cushion. Overall, the technical picture is bearish, the fundamentals remain weak despite recent cash‑flow improvements, and valuation metrics suggest limited upside at present.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and RSI below 40
- Price below 20‑day and 50‑day SMAs
- Decreasing volume and proximity to support
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Positive non‑GAAP earnings and free cash flow
- Strategic partnership announcements
- Continued revenue growth but negative GAAP profitability
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- High beta and volatility indicating market sensitivity
- Overvaluation relative to DCF fair value
- Potential upside from digital identity market if turnaround succeeds
Key Metrics & Analysis
Financial Health
Revenue Growth2.90%
Profit Margin-95.27%
P/E Ratio-52.6
ROE-63.61%
ROA-29.07%
Debt/Equity12.96
P/B Ratio2.4
Op. Cash Flow$-11779000
Free Cash Flow$1.5M
Industry P/E32.0
Technical Analysis
TrendBearish
RSI38.9
Support$4.07
Resistance$6.97
MA 20$5.27
MA 50$5.39
MA 200$8.65
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98
Valuation
Fair Value$1.40
Target Price$8.00
Upside/Downside78.97%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.93
Volatility96.78%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.